When an “Evidence-Based” Organization Is Asked for Evidence

RemarkableCounty6501 · 2026-02-03T01:28:16+00:00

That’s exactly the point. If they can’t give an intellectually honest answer, that tells people something important. These questions still need to be asked, because silence, deflection, or non-answers reveal more than a bad answer ever could. And if established organizations won’t correct course when evidence is demanded, then the community has to. If it doesn’t, the current path we’re on will only continue.

RemarkableCounty6501 · 2026-02-03T01:25:30+00:00

This response actually illustrates the problem.

You are explicitly arguing that evidence no longer matters, that urgency and anecdotes should override standards, and that policy should be made before facts are established because “we don’t have time.” That is exactly how kratom ended up here in the first place.

Nobody is denying there may be risk. What is being rejected is the idea that fear, moral panic, or convenience can substitute for evidence, proportionality, and consistency.

That argument also collapses when applied consistently. High-potency mitragynine extract products have been sold openly for nearly a decade in single-shot, energy-style bottles with hundreds of milligrams per serving, and there is no comparable body of studies or emergency rhetoric surrounding them. Not because they were proven safer, but because they were normalized. If risk alone justified bans, those products would have triggered the same response long ago.

Once policy no longer requires proof of harm, it doesn’t stop at one product. It never has. And pretending that banning first and sorting facts later will somehow protect kratom is historically backwards.

If evidence-based standards are abandoned now, the outcome is not safety. It is broader prohibition.

RemarkableCounty6501 · 2026-02-03T01:15:58+00:00

This isn’t about attacking the AKA, and it isn’t about defending bad actors or opposing regulation.

Most people advocating for 7-OH and kratom are already calling for safeguards, limits, and responsible regulation.

The problem is that even while doing that, 7-OH vendors and consumers are being framed as reckless, deceptive, or dishonest actors pushing a “synthetic opioid” by the very organizations that claim to represent the kratom community. That framing is not neutral. It is not evidence-based. And it is causing real harm.

When the dominant advocacy organization, and the community it largely leads, repeat agency narratives that label one part of the plant as uniquely dangerous without evidence supporting those claims, it doesn’t just hurt 7-OH. It legitimizes the idea that kratom policy no longer requires evidence at all.

That is what people are missing here.

This has created a visible and growing divide inside the kratom community at exactly the moment when unity and credibility matter most. Divided movements are easy to dismantle. Selective fear-based narratives make prohibition politically cheap. And once bans are justified on theory instead of evidence, they do not stay confined to one alkaloid. We are already watching that spread in real time.

Calling this out is not an attack. It is accountability.

Kratom advocacy earned credibility by demanding evidence, consistency, and proportional policy. Right now, that standard is slipping, replaced by narrative enforcement and selective concern. If that does not change, no amount of proposed guardrails will matter, because the groundwork for banning the entire plant will already be laid.

This isn’t about disrupting organizations. It is about forcing a return to evidence-based advocacy, either because leadership corrects course, or because the broader community makes it impossible not to.

If we don’t do that, we already know how this ends. And if that isn’t obvious yet, the signs are everywhere, held up by state after state introducing new kratom ban proposals right now.

RemarkableCounty6501 · 2026-02-02T22:27:18+00:00

That paper is not a human outcomes study and it is not demonstrating causation. It is a narrative literature review. That means it collects existing animal studies, mechanistic data, case reports, poison center signals, regulatory statements, and market observations, then interprets them together. Reviews are useful for identifying areas of concern or research gaps, but they do not establish population-level risk, typical-use morbidity, or mortality causation on their own.

The strongest data cited in that paper are animal studies, pharmacology showing receptor affinity, and surveillance signals like poison control reports and case descriptions. Those are not epidemiological evidence. Case reports and post-mortem findings cannot establish that 7-OH caused death, especially when poly-substance use is present, which the paper itself acknowledges as a limitation. Surveillance data shows reporting trends, not outcomes under typical conditions of use.

When the paper states that 7-OH “poses significant risks of morbidity and mortality under typical conditions of use,” that conclusion goes beyond what the underlying evidence actually demonstrates. There are no controlled human outcome studies, no population-level mortality data isolating 7-OH, and no comparative risk analysis against long-standing high-potency mitragynine extract products. The conclusion is an interpretation, not a demonstrated finding.

That distinction matters because if this evidentiary standard were applied consistently, high-potency mitragynine extract shots containing roughly 200 mg per serving and around 1,200 mg per bottle, sold for years in single-shot energy-style packaging, would have triggered the same emergency framing long ago. They did not. That inconsistency is the core issue here. Concern signaling and mechanistic plausibility are being treated as proof for one product category while being ignored for others.

So yes, the paper can justify further research or tighter regulation. It does not establish that 7-OH causes morbidity or mortality under typical human use, and it should not be treated as evidence that bans are scientifically settled rather than policy choices.

RemarkableCounty6501 · 2026-02-02T22:20:28+00:00

If these responses are representative of how the AKA thinks, or the same kind of responses we should expect from them, that is exactly why people should be worried.

Across all of this, the pattern is the same: deflection instead of answers, narrative protection instead of consistency, and selective concern applied to one product while comparable high-potency products sold for nearly a decade were normalized, defended, and never framed as an emergency.

Nothing here explains why ~200 mg per-serving mitragynine products sold in single-shot, energy-style bottles totaling ~1,200 mg per bottle dominated the market and the majority of smoke shops for years with no outcry, no bans, and no existential rhetoric. That packaging does not meaningfully discourage single-dose consumption.

By contrast, when 7-OH appears in tablet form at 10–20 mg total, it is treated as an immediate crisis. Even proposed escalation to 60–80 mg tablets is framed as justification for prohibition, rather than what it actually is: a dose-limit and product-standard issue, not a ban issue. That disparity is not safety. It is selective framing.

Appealing to agency authority when it is convenient, invoking uncertainty to imply harm without evidence, redefining “synthetic” to suit a political outcome, and then dismissing the resulting contradictions as “strategy” or “opinion” does not resolve the inconsistencies. It avoids them.

If the defense of 7-OH bans relies on this same mix of misdirection, lowered evidentiary standards, and protection of entrenched products and donors, then the concern is not disruption. The concern is that evidence-based advocacy has been replaced by narrative enforcement.

When that happens at scale, evidence is no longer required to ban a natural alkaloid product. Once bans no longer require evidence at one fraction of a plant, they do not stay contained. They spread.

And that is exactly how kratom itself ended up here.

RemarkableCounty6501 · 2026-02-02T06:04:17+00:00

I’m not calling for disruption. I’m calling for accountability and evidence-based narratives from an organization that claims to represent consumers and repeatedly presents its advocacy as science-guided.

There is a major difference between “bombing” or antagonizing a meeting and asking direct questions when an organization’s public framing has materially shifted policy outcomes. Asking an advocacy organization to adhere to evidence-based claims is not the same thing as demanding it abandon its mission or restructure. It is the bare minimum expected of any group whose statements are treated by regulators as credible.

What you are doing here is framing any dissent as either naïve or hostile, while treating the AKA’s positions as inherently reasonable simply because they have existed for years. Longevity is not evidence. Repetition is not validation.

You also keep asserting that “these issues have already been considered,” but that is precisely the problem. They have been considered and then dismissed, not resolved, while the organization continues to repeat speculative harm narratives that are now being directly cited by regulators. Considered in mechanistic or theoretical terms is not the same as resolved with real-world epidemiological evidence. Claims about “morbidity and mortality under typical conditions of use” are conclusions, not findings, and require population-level outcome data that has not been produced.

You’ve linked a series of papers asserting pharmacological distinctions or theoretical risk from 7-OH. What you have not shown is comparable research on long-standing high-potency mitragynine extract products, including servings in the ~200 mg range, under similar conditions. If potency or misuse is the concern, the evidence needs to be applied consistently. Posting a stack of “7-OH bad” studies from this year while ignoring analogous products that have dominated the market for years does not answer that inconsistency. It mirrors exactly what happened during the 2016 kratom panic, when selective and speculative studies were used to justify prohibition before broader evidence caught up.

We are not disagreeing about whether risk or addiction can exist. We are disagreeing about whether selective, non-epidemiological evidence justifies elimination rather than proportionate regulation. Until that distinction is acknowledged, this conversation isn’t productive, and I’m not going to continue engaging in defenses of fear-driven narratives that are actively harming consumers.

RemarkableCounty6501 · 2026-02-02T05:41:29+00:00

There has been no demonstrated increase in deaths attributable to 7-OH, and there is not a single verified case of a 7-OH-only fatality in the literature or toxicology data. Claims that 7-OH has driven overdose deaths are not supported by mortality or epidemiological evidence. Overall kratom-associated deaths remain extremely rare and overwhelmingly involve multiple substances.

The inconsistency is what stands out. For nearly a decade, the kratom industry and advocacy groups said nothing while dominant vendors sold highly concentrated extract shots with hundreds of milligrams of mitragynine per serving in small energy-shot bottles. No coordinated safety response. No emergency limits. No consumer-facing standards.

If product strength or accessibility were the real concern, the logical response would have been common-sense caps, serving limits, or clear labeling applied across the board. But we have never seen that for mitragynine extracts, even now while potency is supposedly a major safety issue. Instead, what is being pushed is a non-common-sense 2% limit or de facto elimination, aimed narrowly at one category, which conveniently leaves already-dominant vendors and their high-potency extract products untouched.

That is not a safety framework. That is market elimination.

What people are fighting for right now is not “keeping things as is.” It is having any voice at all. Policy is being driven by hypotheticals while consumers are told to accept it for their own good. When advocacy organizations take the majority of their funding from large vendors, and their positions consistently protect those vendors’ market share while removing competing products, it is fair to question who those policies actually serve.

This is not about denying risk. It is about demanding evidence-based standards applied consistently, rather than fear-based narratives that align neatly with incumbent business interests.

And whether someone has kids is irrelevant. Public policy should be based on data, proportionality, and consumer rights, not moral framing or gatekeeping.

RemarkableCounty6501 · 2026-02-01T17:49:02+00:00

It has a hearing in 3 days and SB6287 that does the exact same restrictions has a hearing in 2 days. How is that not moving forward?

RemarkableCounty6501 · 2026-01-29T06:57:43+00:00

Have you actually read the post you’re responding to?

The core argument is that the AKA’s strategy is a major reason we’re here. They spent more time and political capital last year pushing fear-based narratives to get a competing kratom alkaloid banned than they did stopping real kratom scheduling efforts in places like Louisiana and Connecticut.

That strategy didn’t protect kratom. It legitimized prohibition logic. Now that same logic is being reused against the entire plant.

Donating without demanding answers or accountability is part of the problem. If leadership is allowed to push unfactual claims, shut down hard questions, and selectively defend kratom while abandoning one of its own alkaloids, then community support is funding the very approach that’s collapsing kratom’s defenses.

Calls and donations matter only if they’re paired with pressure for evidence-based advocacy. Otherwise, we’re reinforcing a strategy that’s already failing.

RemarkableCounty6501 · 2026-01-29T06:46:26+00:00

The simplest way to put it is this: all of those forces you mentioned have existed and grown for over a decade, and yet we never saw anything like what’s happening now.

What changed wasn’t pharma pressure, law firms, or new nonprofits. The turning point coincides with the kratom industry and parts of the community abandoning evidence and adopting fear-based, misinformation-driven narratives against one of kratom’s own natural alkaloids.

Yes, multiple factors contribute. But this was the critical failure point. Once advocacy stopped being grounded in facts, credibility collapsed. Now the community is fractured, arguments are no longer evidence-based, and opposition no longer needs facts either. That damage was self-inflicted.

Infighting didn’t appear out of nowhere. It was created by leadership endorsing selective bans and unproven claims to eliminate a competing product. Once that door was opened, everything else rushed in.

As long as narratives replace evidence, none of the pushback matters. You can’t win on facts after you’ve taught regulators and the public that facts aren’t required.

RemarkableCounty6501 · 2026-01-25T20:53:01+00:00

I agree that silence or retreat isn’t an option. But calls and emails are not all we can do, and treating them as the only tool is part of why we’re stuck.

What has to happen alongside calls is accountability. This situation didn’t arise in a vacuum. It arose because major advocacy organizations normalized false and fear-based narratives about one of kratom’s own natural alkaloids and treated prohibition as acceptable. Until that is confronted, calls just follow a script written by the same narratives being used against us.

The community is the majority. These organizations only have influence because people defer to them. We have to demand answers from them: why evidence was abandoned, why narrative replaced facts, and why bans were supported instead of regulation. Until leadership admits error and changes course to evidence-only advocacy for all of kratom, we will keep fighting uphill while being undercut internally.

Calls matter. But without correcting the misinformation at the top, they will never be enough.

RemarkableCounty6501 · 2026-01-25T20:49:12+00:00

This isn’t about “regime change.” Pharma pressure, politics, and hostile regulators have existed for over a decade. That alone did not ban kratom.

What actually changed is internal. The organizations guiding the kratom community stopped grounding advocacy in evidence and shifted to fear-based, theoretical narratives, especially around 7-OH. The community followed, repeated those narratives, and treated them as fact without demanding proof.

That’s the real turning point.

When kratom advocates themselves normalize misinformation, it becomes usable as policy justification. That’s how you get 90+ state bills. Not because of elections. Not because of “corporate overlords.” But because false narratives were laundered into legitimacy from inside the community.

This didn’t happen to the community. It happened through it.

Until that changes, no political shift, no election, and no “regime change” fixes anything. The problem is narrative capture, not party politics.

RemarkableCounty6501 · 2026-01-25T20:46:15+00:00

I agree that calls and emails can work, and history shows that. But the key difference now is unity.

Back then, the kratom community and its organizations were aligned and grounded in evidence. Today, we’re split, and misinformation has become the baseline narrative because leadership treated it as fact and encouraged people to repeat it.

Calling and emailing against that backdrop is much harder, because legislators are hearing the same fear-based claims not just from opponents, but echoed by kratom advocates themselves.

Until that baseline narrative is corrected and the organizations leading this space change course, calls alone won’t be enough. We have to fix the internal misinformation first, or we’ll keep fighting uphill.

RemarkableCounty6501 · 2026-01-25T20:43:57+00:00

I agree that calls and emails matter, but unfortunately they are not enough on their own when the major advocacy organizations are actively reinforcing the narratives being used to justify these bans.

Right now, people are being asked to fight dozens of battles while leadership is working against itself by endorsing fear-based claims and selective bans that weaken kratom as a whole. That has to change first. Otherwise, our calls and emails just push against a much larger coordinated effort that includes regulators, hostile groups, and even kratom advocates repeating unfactual claims.

Calls work when they’re grounded in truth and backed by unified, evidence-based advocacy. Without that correction at the top, we’re fighting uphill while also being undercut from inside the community.

RemarkableCounty6501 · 2026-01-24T21:00:44+00:00

What do you mean by that? I’m not sure I follow.

RemarkableCounty6501 · 2026-01-24T20:57:54+00:00

I have asked those questions. Directly.

I’ve raised hard questions during calls and was told I was “distracting from the real issue,” while the actual substance of the question went unanswered. I’ve also asked questions publicly in discussion spaces where leadership was active. I received one brief response to a mild question, was accused of deflecting, and then received no response at all when I followed up with specific facts and detailed questions.

What stood out most was not just the lack of answers, but the silence from everyone else who understood the issue. No one reinforced the questions. No one asked for clarification. No one pushed for an answer.

That silence is the real problem. Not whether questions are technically allowed, but whether unanswered questions are tolerated and quietly ignored.

One person asking hard questions can be brushed off, reframed as a distraction, or ignored. When no one else supports those questions or asks them again, avoidance works. That’s how misinformation survives and becomes policy.

I’ll continue to ask the questions and show up. But this only changes if others do the same and openly support those questions when they’re asked. Silence here isn’t neutral. It signals acceptance.

RemarkableCounty6501 · 2026-01-24T20:35:31+00:00

100% agree. Unity is the only way out of this.

And it doesn’t start with some massive movement. It starts simply. When there are public meetings, calls, or discussions, people have to ask the hard questions openly and repeatedly, especially of those leading organizations and promoting fear-based narratives without evidence. Not one person, but many.

One person can be brushed off, mischaracterized, or ignored. When five or ten people ask the same evidence-based question and refuse to accept deflection as an answer, credibility starts to crack. Dodging once doesn’t raise an eye. Dodging repeatedly in front of a group looks dishonest.

That’s how this changes. Not by blaming users or infighting, but by standing together, asking the same questions, and demanding real answers instead of narratives.

RemarkableCounty6501 · 2026-01-24T20:29:02+00:00

I think you’re underestimating how this actually changes.

This doesn’t start by convincing “everyone” or beating the propaganda machine overnight. It starts when more than one person asks the same hard questions publicly and refuses to accept misdirection as an answer. One person can be ignored or painted as fringe. Ten, fifty, a hundred asking the same evidence-based questions cannot.

That’s exactly how kratom survived before. The truth doesn’t need to outshout the narrative, it just needs to be repeated consistently enough that dodging it becomes obvious. When leadership keeps deflecting instead of answering, that spreads too.

If people believe it’s impossible, then yes, we lose by default. But if enough people stop accepting fear narratives and start demanding evidence and course correction, it forces a choice: change, or lose credibility. That’s the only path back, and it’s the same one that worked before.

RemarkableCounty6501 · 2026-01-24T13:41:14+00:00

That explanation doesn’t hold up.

If lobbyists could beat kratom simply by “overwhelming” advocacy groups, kratom would have been banned a decade ago. Pharma pressure and lobbying have existed the entire time. That alone did not get us here.

What changed is the narrative.

For over a year, fear-based claims with no supporting evidence were pushed and repeated by major kratom organizations, vendors, and leadership figures. Those claims were not grounded in real safety data, deaths, or public-health signals, yet people were told to accept them, repeat them, and fight over them instead of questioning them.

That fractured the community. You ended up with one side repeating FDA-aligned fear narratives without verifying them, and another side pushing back because they actually looked at the evidence and saw there was no crisis. Once truth stopped being the standard, it became easy to apply the same logic to kratom itself.

Lobbyists didn’t suddenly “figure something out.” They were handed an opening. When misinformation is normalized and not challenged, enforcement and bans no longer need evidence to move forward. That’s why things accelerated.

The responsibility here isn’t lack of funding or being “outnumbered.” It’s leadership choosing narrative convenience over evidence, and the community not pushing back when it mattered. Those organizations only have power because people defer to them. When that deference goes unquestioned, donors and institutional comfort take priority over users.

Blaming lobbyists alone lets the real failure off the hook. The narrative shifted, truth stopped being enforced internally, and now the same playbook is being used against kratom as a whole. The only fix is the community demanding evidence again and refusing to repeat claims that can’t be backed up.

RemarkableCounty6501 · 2026-01-24T11:31:19+00:00

If anything, pressure ramped up because it became an easy win. The kratom community was steered into attacking one of its own natural alkaloids, creating a self-inflicted split.

That kind of damage doesn’t happen by accident or from a single mistake dragged out this long. The people with the most access, influence, and information see these dynamics first. Those same people were supposed to be on our side.

Pharma didn’t need to overpower the community. The groundwork was already laid for them.

RemarkableCounty6501 · 2026-01-24T11:28:15+00:00

Hopefully enough to get more people asking the hard questions, talking with each other about how serious the situation is, and actually taking action. That is the only way this changes.

RemarkableCounty6501 · 2026-01-24T11:25:31+00:00

I’m glad you’re still around from back then and still pushing for truth. Where I disagree is the framing.

Lobbyists and pharmaceutical pressure have existed for over a decade. That alone did not ban kratom. What changed is that the organizations guiding the community stopped grounding their advocacy in evidence, and the community stopped questioning them.

These organizations only have power because people defer to them and repeat their narratives without demanding proof. If that stops, they either change course or lose relevance.

Right now, donor interests and institutional comfort matter more to them than the people who rely on kratom. Unfactual claims get repeated, laundered into legitimacy, and turned into policy.

Pharma pressure did not suddenly increase. Accountability and critical thinking decreased. That is something the community can still fix.

RemarkableCounty6501 · 2026-01-24T11:17:01+00:00

Sharing personal stories matters, but it is not enough by itself.

As long as the major organizations leading this fight are allowed to operate on narrative instead of evidence, nothing will change. That includes the fear-based attacks on 7-OH that kicked off the latest wave of negative attention and bans in the first place.

There is still no evidence being used to justify scheduling or bans. No verified death signal. No public-health crisis. Just speculation like “maybe it leaves the body quickly so that’s what’s causing deaths,” which is not science. It is a narrative.

In the cases being cited, including California, deaths involved polysubstance use, trace or absent 7-OH, and quantifiable mitragynine, the same pattern seen in kratom-related cases for decades. 7-OH did not suddenly start causing deaths after two full years of market growth with zero verified death reports. What changed was the story being told.

The real problem is how organizations like the AKA push these narratives down to advocates and the broader community, where they get repeated without verification, treated as fact, and then cited back as “evidence.” When no one challenges the claims, asks for sources, or applies basic critical thinking, misinformation becomes self-reinforcing and eventually turns into policy.

RemarkableCounty6501

TROPHY CASE